The Toedebusch Laboratory is dedicated to improving outcomes for dogs and cats with brain tumors while generating discoveries that inform and advance human medicine.
A central focus of our research is canine glioma, a uniformly fatal primary brain tumor that represents one of the most significant unmet needs in veterinary and human neuro-oncology.
Our work is grounded in a comparative oncology framework, leveraging the striking similarities between naturally occurring gliomas in dogs and those in humans.
By integrating molecular, immunologic, and clinical data across species, we aim to identify novel therapeutic targets and strategies that can benefit glioma patients—both two—and four-legged.
